essence semaglutide 2.4 mg in Participants With Metabolic Dysfunction‐Associated Steatohepatitis: Baseline Characteristics and Design of the Phase 3 Trial Semaglutide Receives FDA Approval for

Food & Drug Administration suggests that fewer than 10% of semaglutide users experience dizziness or lightheadedness

Another randomised study, (called STEP 3), indicated a potential loss of 5% using Wegovy and just over 4% on a placebo

Use alcohol pad to wipe the injection site (your skin) and a separate pad to wipe the top of the vial prior to pulling medication from vial

Should I increase past 50 units Only if you meet three criteria: (1) you have been on the current dose for at least four weeks, (2) weight loss has stalled or appetite suppression has weakened, and (3) your provider agrees an increase is appropriate

Like many people on semaglutide, McCullar has suffered with mild nausea and constipation, but found herbal tea helps

Do not leave the vial sitting on a countertop in a sunny kitchen while you prepare your injection